Autoinjectors for administration of interferon beta-1b in multiple sclerosis: patient preferences and the ExtaviPro™ 30G and Betacomfort(®) devices

BACKGROUND: The ExtaviPro™ 30G autoinjector has been developed for self-administration of interferon beta-1b (Extavia(®)), which is used as a first-line, parenteral, disease-modifying therapy in multiple sclerosis (MS). The aim of this survey was to investigate patients’ perceptions of the importanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakur, Kunal, Manuel, Laure, Tomlinson, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045013/
https://www.ncbi.nlm.nih.gov/pubmed/27774021
http://dx.doi.org/10.2147/POR.S51838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045013/
https://www.ncbi.nlm.nih.gov/pubmed/27774021
http://dx.doi.org/10.2147/POR.S51838

Ejemplares similares